SCHEMBL30737368

SCHEMBL30737368

C#CCOCCOCCOCCOCCOCCOCCNC(=O)COc1cccc(Oc2ccc(CN[C@@H](CCC(C)(C)C)C(=O)OC)cn2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 3/20 0.42
GRN P28799 2/20 0.37
PPARD Q03181 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NCF1 P14598 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ACACA Q13085 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
HPGD P15428 1/20 0.30
EGLN1 Q9GZT9 1/20 0.30
ROCK2 O75116 1/20 0.30
TSHR P16473 1/20 0.30
RECQL P46063 1/20 0.30
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737227 0.88 SORT1 (0.53) SORT1GRNCYP1A2CYP2C9CYP2C19
SCHEMBL31646330 0.88 SORT1 (0.53) SORT1GRNCYP1A2CYP2C9CYP2C19
SCHEMBL30737487 0.85 SORT1 (0.49) SORT1GRNKMT2A
SCHEMBL30737248 0.82 SORT1 (0.48) SORT1GRNACACASIRT2ALDH1A1
SCHEMBL30737126 0.81 SORT1 (0.44) SORT1GRNKDM4EACACASIRT2
SCHEMBL31646637 0.79 SORT1 (0.45) SORT1GRNCYP1A2CYP2C9CYP2C19
SCHEMBL30737013 0.79 CD274 (0.36) KDM4ESIRT2ALDH1A1MEN1KMT2A
SCHEMBL30737203 0.77 SORT1 (0.47) SORT1GRNCYP1A2CYP2C9CYP2C19
SCHEMBL30737266 0.75 SORT1 (0.37) SORT1GRNACACALMNAKMT2A
SCHEMBL30737357 0.75 SORT1 (0.45) SORT1GRNLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 SORT1 1/4885GRN 842/4885PPARD 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.